Johnson & Johnson's Independence Technology subsidiary, based in Warren, New Jersey, USA, was established in 1999 to develop and market an advanced gyro-balanced, battery-operated mobility system. The device, known as the Independence iBOT Mobility System, was invented by Dean Kamen, founder of DEKA Research & Development. J&J has been in partnership with this company since 1995 for the development of the iBOT, a wheelchair which can be operated on two or four wheels, stabilising the user by automatically adjusting and balancing itself using a combination of electronic, sensor and software components.

The system's features include the ability to allow a seated user to move and interact with others at eye-level while the wheelchair is balanced on two wheels. Its rotating four-wheel base is designed to allow the user to climb stairs and traverse uneven terrain while keeping them level and balanced. The company's latest system, the iBOT 4000 Mobility System, received FDA approval in March 2005.

Independence Technology's current focus is to receive reimbursement approval in the US for the system. In September 2005, it submitted a Request for a National Coverage Determination (NCD) to the Centers for Medicare and Medicaid Services (CMS). However, in July 2006, the CMS determined it would class iBOT 4000 as a standard wheelchair. Independence Technology is in the process of challenging this decision. The company is also awaiting the final determination on its assigned pay-out level.